$CYN
Cyngn Inc. Stock $cyn

$cyn Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023084879 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$40.36K	$25.21K
YoY Change	-84.6%
Cost Of Revenue	$100.6K	$42.41K
YoY Change	-46.16%
Gross Profit	-$60.23K	-$17.20K	$0.00
YoY Change	-180.11%
Gross Profit Margin	-149.23%	-68.24%
Selling, General & Admin	$2.313M	$2.663M	$2.552M
YoY Change	-21.53%	4.34%	162.07%
% of Gross Profit
Research & Development	$3.023M	$2.929M	$2.726M
YoY Change	7.25%	7.46%	136.81%
% of Gross Profit
Depreciation & Amortization	$253.9K	$89.63K	$42.29K
YoY Change	31.33%	111.95%	85.62%
% of Gross Profit
Operating Expenses	$5.336M	$2.929M	$5.278M
YoY Change	-7.46%	-44.5%	148.39%
Operating Profit	-$5.396M	-$5.610M	-$5.278M
YoY Change	-5.18%	6.28%	148.39%
Interest Expense	$39.19K	$32.91K	$4.680K
YoY Change	-5.36%	603.21%	-217.29%
% of Operating Profit
Other Income/Expense, Net	-$790.00	$138.2K	$18.97K
YoY Change	-100.77%	628.35%	-36.46%
Pretax Income	-$5.358M	-$5.472M	-$5.259M
YoY Change	-3.4%	4.03%	150.54%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.358M	-$5.472M	-$5.259M
YoY Change	-3.4%	4.03%	150.54%
Net Earnings / Revenue	-13274.43%	-21703.74%
Basic Earnings Per Share		-$0.14	-$0.16
Diluted Earnings Per Share	-$0.11	-$0.14	-$0.16
COMMON SHARES
Basic Shares Outstanding	41.80M shares	33.99M shares	33.63M shares
Diluted Shares Outstanding		37.77M shares	33.64M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.154M	$8.156M	$27.62M
YoY Change	-63.92%	-70.47%	1573.18%
Cash & Equivalents	$3.592M	$3.500M	$5.631M
Short-Term Investments	$4.562M	$4.619M	$21.99M
Other Short-Term Assets	$9.526K	$436.9K	$586.8K
YoY Change	-99.19%	-25.54%	59.54%
Inventory
Prepaid Expenses	$385.5K
Receivables
Other Receivables	$765.7K
Total Short-Term Assets	$9.470M	$8.593M	$28.21M
YoY Change	-60.17%	-69.54%	1297.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.487M	$1.393M	$654.6K
YoY Change	68.18%	112.85%	832.54%
Goodwill
YoY Change
Intangibles	$1.084M	$1.160M	$364.4K
YoY Change	129.23%	218.25%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.563M	$2.958M	$1.527M
YoY Change	106.18%	93.72%	1397.24%
TOTAL ASSETS
Total Short-Term Assets	$9.470M	$8.593M	$28.21M
Total Long-Term Assets	$3.563M	$2.958M	$1.527M
Total Assets	$13.03M	$11.55M	$29.73M
YoY Change	-48.9%	-61.15%	1302.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$197.0K	$234.4K	$299.1K
YoY Change	26.3%	-21.64%	11.08%
Accrued Expenses	$214.3K	$245.4K	$47.39K
YoY Change	-24.31%	417.85%	-72.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.081M	$1.348M	$945.7K
YoY Change	49.97%	42.5%	93.87%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$317.3K
YoY Change
Total Long-Term Liabilities	$317.3K	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.081M	$1.348M	$945.7K
Total Long-Term Liabilities	$317.3K	$0.00	$0.00
Total Liabilities	$2.398M	$1.348M	$945.8K
YoY Change	72.84%	42.5%	-54.77%
SHAREHOLDERS EQUITY
Retained Earnings	-$160.0M	-$153.2M	-$130.2M
YoY Change	17.88%	17.68%
Common Stock	$648.00	$352.00	$337.00
YoY Change	92.28%	4.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.600M	$4.600M	$22.00M
YoY Change	-61.98%	-79.09%
Treasury Stock Shares
Shareholders Equity	$10.64M	$10.20M	$28.79M
YoY Change
Total Liabilities & Shareholders Equity	$13.03M	$11.55M	$29.73M
YoY Change	-48.9%	-61.15%	1302.18%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$5.358M	-$5.472M	-$5.259M
YoY Change	-3.4%	4.03%	150.54%
Depreciation, Depletion And Amortization	$253.9K	$89.63K	$42.29K
YoY Change	31.33%	111.95%	85.62%
Cash From Operating Activities	-$5.038M	-$4.190M	-$4.596M
YoY Change	7.18%	-8.84%	114.71%
INVESTING ACTIVITIES
Capital Expenditures	$141.4K	$424.4K	-$229.3K
YoY Change	-49.28%	-285.13%	3400.15%
Acquisitions
YoY Change
Other Investing Activities	$134.4K	$4.084M	$4.839M
YoY Change	-98.64%	-15.6%	10153.4%
Cash From Investing Activities	-$7.000K	$3.659M	$4.609M
YoY Change	-100.07%	-20.61%	11241.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.100M	1.011M	16.51K
YoY Change		6023.8%	-558.61%
NET CHANGE
Cash From Operating Activities	-5.038M	-4.190M	-4.596M
Cash From Investing Activities	-7.000K	3.659M	4.609M
Cash From Financing Activities	5.100M	1.011M	16.51K
Net Change In Cash	55.24K	480.1K	29.47K
YoY Change	-98.87%	1529.15%	-101.4%
FREE CASH FLOW
Cash From Operating Activities	-$5.038M	-$4.190M	-$4.596M
Capital Expenditures	$141.4K	$424.4K	-$229.3K
Free Cash Flow	-$5.179M	-$4.615M	-$4.367M
YoY Change	4.02%	5.67%	104.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40932
	dei	Entity Registrant Name EntityRegistrantName	CYNGN INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2007094
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1015 O’Brien Dr.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Menlo Park
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94025
	dei	City Area Code CityAreaCode	(650)
	dei	Local Phone Number LocalPhoneNumber	924-5905
	dei	Security12b Title Security12bTitle	Common stock, $0.00001
	dei	Trading Symbol TradingSymbol	CYN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41802944	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3536381	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10536273	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	50000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	4619260	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	12064337	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	436923	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1126137	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8592564	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23776747	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1393393	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	884000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	404868	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	371189	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1159642	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	473076	usd
CY2023Q3	us-gaap	Assets Assets	11550467	usd
CY2022Q4	us-gaap	Assets Assets	25505012	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	234357	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	155943	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	699953	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	854920	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	413371	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	376622	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1347681	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1387485	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35205748	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35205748	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33684864	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33684864	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	352	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	337	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	163386142	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	159847229	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-153183708	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135730039	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10202786	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24117527	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11550467	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25505012	usd
CY2023Q3	us-gaap	Revenues Revenues	25210	usd
	us-gaap	Revenues Revenues	1448961	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	42414	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1121732	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2929225	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2725919	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9697099	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6662730	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2663272	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2552418	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8580113	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7047181	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	5634911	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	5278337	usd
	us-gaap	Costs And Expenses CostsAndExpenses	19398944	usd
	us-gaap	Costs And Expenses CostsAndExpenses	13709911	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5609701	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5278337	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17949983	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13709911	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	32905	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4677	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	98698	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2691	usd
CY2023Q3	us-gaap	Other Income OtherIncome	105284	usd
CY2022Q3	us-gaap	Other Income OtherIncome	14296	usd
	us-gaap	Other Income OtherIncome	397616	usd
	us-gaap	Other Income OtherIncome	16856	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	138189	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18973	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	496314	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19547	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-5471512	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-5259364	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17453669	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13690364	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37771928	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37005071	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37344276	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33458338	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	33272539	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16511	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	757122	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-5259364	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	28786808	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13942044	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1012511	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	460	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	719283	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-5471512	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10202786	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22247562	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	114169	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11989509	usd
	cyngn	Stock Issued During Period Value Issuance Of Common Warrants At Fair Value In Connection With The Private Placement StockIssuedDuringPeriodValueIssuanceOfCommonWarrantsAtFairValueInConnectionWithThePrivatePlacement	6132436	usd
	cyngn	Stock Issued During Period Value Issuance Of Common Stock Upon Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueIssuanceOfCommonStockUponExerciseOfPrefundedWarrants	2662	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1990834	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13690364	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	28786808	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24117527	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1012511	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	8527	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2517890	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17453669	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10202786	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17453669	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13690364	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	707337	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	411512	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2517890	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1990834	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	396141	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	13541	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-261034	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	835747	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	78414	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	186797	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-154967	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	351524	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14440102	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11598985	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	904417	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	639545	usd
	cyngn	Disposal Of Assets DisposalOfAssets	130898	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	698527	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	340850	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	17050782	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	27000000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	24892000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5025879	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6369172	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22954516	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	1012511	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	18121945	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2662	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8527	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	114169	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1021038	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18238776	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7049892	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-16314725	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10586273	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21995981	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3536381	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5681256	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	3536381	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	5631256	usd
CY2022Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	50000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3536381	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5681256	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	464929	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	824292	usd
	cyngn	Acquisition Property And Equipment Included In Accounts Payable And Accrued Expenses AcquisitionPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses	20625	usd
	cyngn	Acquisition Property And Equipment Included In Accounts Payable And Accrued Expenses AcquisitionPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses	28854	usd
	cyngn	Incurred Net Losses IncurredNetLosses	17500000	usd
	cyngn	Incurred Net Losses IncurredNetLosses	13700000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-153200000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135700000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	14400000	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	11600000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3500000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	4600000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10500000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	12100000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments include but are not limited to internal-use software and developed software to be sold, leased or marketed, warrants and share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates. </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times exceeds federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p>
CY2023Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	3500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	10500000	usd
	cyngn	Property Plant And Equipment Useful Life Term PropertyPlantAndEquipmentUsefulLifeTerm	Shorter of 3 years or lease term
CY2023Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P15Y
CY2022Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	100000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6451613	shares
	us-gaap	Revenues Revenues	1400000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	5794	usd
CY2023Q3	us-gaap	Amount Of Deferred Costs Related To Long Term Contracts AmountOfDeferredCostsRelatedToLongTermContracts	25358	usd
CY2022Q4	us-gaap	Amount Of Deferred Costs Related To Long Term Contracts AmountOfDeferredCostsRelatedToLongTermContracts	114654	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	4600000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	12100000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2180604	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1407084	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	787211	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	523084	usd
CY2023Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1393393	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	884000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	89625	usd
CY2022Q3	us-gaap	Depreciation Depreciation	42285	usd
	us-gaap	Depreciation Depreciation	264127	usd
	us-gaap	Depreciation Depreciation	87690	usd
CY2023Q3	cyngn	Credit Card Payable CreditCardPayable	7029	usd
CY2022Q4	cyngn	Credit Card Payable CreditCardPayable	5194	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	245409	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	283118	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	447515	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	566608	usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	699953	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	854920	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	48000	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	157350	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	262248	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	419598	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6227	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	413371	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M1D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0246	pure
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	100251	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	142037	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	393162	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	375610	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	149051	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	135326	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	431250	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	316436	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1207348	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	47706	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1159642	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	508821	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35745	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	473076	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4751	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4798	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11960	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7385	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35205748	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35205748	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33684864	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33684864	shares
CY2023Q2	cyngn	Gross Proceeds Percentage GrossProceedsPercentage	0.03	pure
	cyngn	Net Proceeds NetProceeds	1012511	usd
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	21051	usd
	us-gaap	Other Expenses OtherExpenses	25000	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	3790322	shares
	cyngn	Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares	2661291	shares
	cyngn	Common Warrants CommonWarrants	6451613	shares
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	3.09
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.98
	cyngn	Gross Proceeds GrossProceeds	20000000	usd
CY2023Q3	cyngn	Warrants Outstanding WarrantsOutstanding	6591613	shares
	cyngn	Fair Value FairValue	6302833	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5471512	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5259364	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	37771928	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	37005071	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17453669	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13690364	usd
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	37344276	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	33458338	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.
CY2023Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2500000	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3600000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14715110	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.23
CY2022Q4	cyngn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y10M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2571013	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2451000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.03
	cyngn	Stocks Issued During Period Shares Stock Options Exercised StocksIssuedDuringPeriodSharesStockOptionsExercised	25750	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.33
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16403	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1423106	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.62
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15717254	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.16
CY2023Q3	cyngn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y3M25D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1574941	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	15717254	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.16
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y3M25D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1574941	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	7984039	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y8M19D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1574941	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	108000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.05
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	134514	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5.52
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	189522	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.55
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.74
	cyngn	Fair Value Of Common Stock FairValueOfCommonStock	1.02
	cyngn	Fair Value Of Common Stock FairValueOfCommonStock	1.76
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0363	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.026	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5274	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.403	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	cyngn	Stockbased Compensation Expense From Stock Options StockbasedCompensationExpenseFromStockOptions	719283	usd
CY2022Q3	cyngn	Stockbased Compensation Expense From Stock Options StockbasedCompensationExpenseFromStockOptions	757122	usd
	cyngn	Stockbased Compensation Expense From Stock Options StockbasedCompensationExpenseFromStockOptions	2517890	usd
	cyngn	Stockbased Compensation Expense From Stock Options StockbasedCompensationExpenseFromStockOptions	1990834	usd
	cyngn	Unrecognized Stock Based Compensation Weighted Average Period UnrecognizedStockBasedCompensationWeightedAveragePeriod	P2Y10M24D
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	cyngn	Common Stocks Dividend Rate Percentage CommonStocksDividendRatePercentage	0.10	pure
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q3	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33458338	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37005071	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37344276	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37771928	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	cyngn	Disposal Of Assets DisposalOfAssets		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet		usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37005071	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37771928	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	33458338	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37344276	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2023Q3	cyngn	Aggregate Intrinsic Value Granted AggregateIntrinsicValueGranted		usd
CY2023Q3	cyngn	Aggregate Intrinsic Value Cancelledforfeited AggregateIntrinsicValueCancelledforfeited		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001874097

Files In Submission

Name	View Source	Status
cyngn-20230930_pre.xml	Edgar Link	unprocessable
cyngn-20230930_cal.xml	Edgar Link	unprocessable
cyngn-20230930_def.xml	Edgar Link	unprocessable
cyngn-20230930_lab.xml	Edgar Link	unprocessable
0001213900-23-084879-index-headers.html	Edgar Link	pending
0001213900-23-084879-index.html	Edgar Link	pending
0001213900-23-084879.txt	Edgar Link	pending
0001213900-23-084879-xbrl.zip	Edgar Link	pending
cyngn-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_cyngn.htm	Edgar Link	pending
f10q0923ex31-2_cyngn.htm	Edgar Link	pending
f10q0923ex32-1_cyngn.htm	Edgar Link	pending
f10q0923_cyngn.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_cyngn_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYN
Cyngn Inc. Stock $cyn

2023 Q4 Form 10-Q Financial Statement

#000121390023084879 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN Cyngn Inc. Stock $cyn

2023 Q4 Form 10-Q Financial Statement

#000121390023084879 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN
Cyngn Inc. Stock $cyn